The global Chiral Chemicals Market is expected to achieve a valuation of $150 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 10% from 2023 to 2030. The escalating demand for chiral chemicals can be attributed to factors such as the expanding global population, diminishing arable land, and evolving climate conditions affecting food security worldwide.
The global Chiral Chemicals Market is expected to achieve a market size of $150 billion by 2030, displaying a Compound Annual Growth Rate (CAGR) of 10% from 2023 to 2030. Chiral chemical refers to a chemical compound with an asymmetrical carbon atom in the molecule's center. It can be summarized as a molecule that is not identical to its mirror image. These mirror images are known as enantiomers that have left-hand and right-hand non-superimposable configurations.
The demand for chiral chemicals is increasing, owing to the growing population, declining arable land, and changing climate conditions related to food security across the globe. In addition, chiral chemicals are used in the production of herbicides, pesticides, plant growth regulators, fungicides, and pheromones for optimum agricultural productivity, which in turn contribute to market growth.
Also, the growing demand in the pharmaceutical industry is driving the growth of the chiral chemicals market, as the chiral chemicals are used in the synthesis process for the development of drugs for cancer therapies, antihistamines, antivirals, anorexics, antibiotics, and anti-diabetics.
Moreover, the use of chiral chemicals is increasing in the cosmetic industry, owing to a surge in demand for naturally derived fragrances such as terpenes which are natural components of essential oils used in the chiral synthesis for fragrances and flavors, which in turn drives the growth of the chiral chemicals market.
However, rising environmental issues such as industrial pollution due to the massive use of chiral compounds in chemical factories and limited availability of raw materials are expected to restrain the growth of the market during the forecast period. On the other hand, various market players have been involved in the research & and development of chiral hormone chemicals, anti-infective chemicals, cardiovascular chemicals, central nervous system chemicals, antidepressants, and respiratory chemicals are expected to create lucrative growth opportunities for the chiral chemicals market players in the future.
Market Segmentations and Scope of the Study
The chiral chemicals market size has been segmented based on separation technique, technology, application, and geography. Based on the separation technique, the market is classified into high-performance liquid chromatography (HPLC), ultra-high performance liquid chromatography (UHPLC), supercritical fluid chromatography (SFC), and simulated moving bed (SMB).
Based on technology, the market is divided into traditional separation methods, asymmetric preparation methods, biological separation methods, and others. The asymmetric preparation method segment is further classified into asymmetric synthesis method and asymmetric catalysis method.
Based on application, the market is grouped into pharmaceuticals, agrochemicals, food & and beverage, cosmetics, and others. The geography breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
Asia-Pacific region holds the lion's share of the chiral chemicals market at present and is expected to boost the market growth during the forecast period. The growing population in countries such as China, India, and Indonesia coupled with the increase in the demand for food is encouraging agricultural activities. This is further driving the demand for the chiral chemicals market in the agriculture sector in the region.
Competitive Landscape
The chiral chemicals market includes various market players such as Chiral Technologies, Corden Pharma International, Clariant, BASF SE, Daicel Chiral Technologies, Boulder Scientific Company, Cambrex Corporation, Chiral Quest (Suzhou) Co., Ltd., Chiral BioSciences Ltd., Beckman Coulter, Agilent Technologies, Inc., Alps Pharmaceutical Ind. Co Ltd., and Buchler. These manufacturers are actively indulging in acquisitions, product & and technology innovations, and collaborations to enhance their productivity and increase their growth as well as geographical reach.
The chiral chemicals market report provides a quantitative analysis of the current market and estimations through 2022-2030 that assist in identifying the prevailing market opportunities to capitalize on.
The study comprises a deep dive analysis of the current and future chiral chemicals market trends, for depicting the prevalent investment pockets in the market.
The information related to key drivers, restraints, and opportunities and their impact on the Chiral Chemicals market is provided in the report.
The competitive analysis of the market players along with their market share in the Chiral Chemicals market
The SWOT analysis and Porter's Five Forces model are elaborated in the study.
Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing uses a single pricing dimension called Product Access (Units). It is offered at no cost, so you subscribe without a fee. There are no tiers, instance sizes, or usage add-ons to compare. Access is granted per unit to subscribers. Once you subscribe, the vendor delivers the market research report in a digital format, typically by email or download link. Because only one dimension exists, your pricing choice is straightforward: you either subscribe for access or you do not. There is no scaling logic or quantity-based charge to weigh.
Top-of-mind questions for buyers
What does one unit of Product Access give me?
One unit grants a subscriber access to the market research report tied to this listing. Access is per subscriber. There is no metering of usage, data volume, or seats beyond that access grant. You subscribe once to receive the report and its associated content.
How and when do I receive the report after subscribing?
After your purchase is confirmed, the report is delivered by email to your registered address. Reports are available for download within 24 to 48 hours of payment confirmation. Delivery may take longer if customization is requested. Reports come in digital formats such as PDF, Excel, or Word.
Does my cost change based on how much I use the report?
No. This listing has one dimension offered at no cost. There is no usage metering, no tier boundaries, and no quantity-based charge. Once you subscribe, access does not accrue additional fees based on how often you open or use the delivered report.
www.nextmsc.com
Helpful?
Vendor refund policy
Not applicable - product available free of charge.
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Chiral by N-21 AI is a clinical-grade agentic AI platform for Medicare Advantage and Dual-Eligible risk adjustment. It improves coding accuracy, reduces RADV exposure, and protects RAF revenue through a closed-loop, human-governed workflow spanning the entire HCC lifecycle, from suspecting and coding to evidence validation and RADV audit support. Every diagnosis is linked to explainable, audit-ready clinical evidence, enabling accurate, defensible RAF capture. HIPAA-compliant, SOC 2 Type II, and deployable securely within your AWS environment.
60-minute live analyst briefing on the Chiral Chemicals Market (2026–2035), helping specialty chemical and pharmaceutical leaders optimize AWS-cloud roadmaps for predictive manufacturing, R&D intelligence, and supply chain resilience.
The global Chiral Chemicals Market is projected to achieve a substantial size, reaching $149.95 billion by 2030, exhibiting a notable CAGR of 9.8% from 2023 to 2030. The escalating demand for chiral chemicals is fueled by factors including a burgeoning population, shrinking arable land, and the impact of changing climate conditions on food security. This upward trajectory underscores the market's significance in addressing critical challenges and adapting to evolving environmental dynamics.